Coloplast A/S
Coloplast A/S - 9M 2024/25 Earnings Release - Invitation to conference call on 19 August 2025 at 11.00am CEST
Coloplast A/S - 9M 2024/25 Earnings Release - Invitation to conference call on 19 August 2025 at 11.00am CEST
Tuesday, 19 August 2025 at 11.00 - 12.00h CEST
In connection with the publication of Coloplast’s interim financial results for 9M 2024/25, to be released same day in the morning around 07.30h CEST, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.
The webcast of the conference call will be available during and after the event.
Coloplast will be represented by:
Lars Rasmussen - Interim CEO
Anders Lonning-Skovgaard - Executive Vice President, CFO
Aleksandra Dimovska - Vice President, Investor Relations
Kristine Husted Munk - Senior Manager, Investor Relations
Simone Dyrby Helvind - Senior Manager, Investor Relations
Webcast
For participants who do not wish to actively participate in the Q&A session, please access the conference call as a webcast via the link below:
Access the webcast here
Dial-in details
To actively participate in the Q&A session, please sign up ahead of the conference call on the link below to receive an email with dial-in details.
Register for the conference call here
For more information, please contact:
Aleksandra Dimovska - Vice President, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2458. E-mail: dkadim@coloplast.com
Kristine Husted Munk - Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3266. E-mail: dkkhu@coloplast.com
Simone Dyrby Helvind - Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2981. E-mail: dksdk@coloplast.com
Julie Sommer Müggler - Coordinator & PA, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3161. E-mail: dkjusm@coloplast.com
Coloplast will be available on individual phone lines after the conference call for further questions.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S8.8.2025 15:15:45 CEST | Press release
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Harvia Oyj8.8.2025 15:00:21 CEST | Press release
Harvia Plc: Disclosure under chapter 9, section 10 of the securities market act
Jelenew8.8.2025 14:46:46 CEST | Press release
Jelenew Supports the Growth of Women’s Cycling at 2025 La Périgord Ladies
Standard Lithium8.8.2025 14:30:12 CEST | Press release
Standard Lithium Reports Second Quarter 2025 Results
Junshi Biosciences8.8.2025 14:00:00 CEST | Press release
Junshi Biosciences Announces the Acceptance of the sNDA for Toripalimab as the 1st-line Treatment of HER2-expressing Urothelial Carcinoma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom